title: Subcutaneous fat necrosis with hypercalcemia.
abstract: Subcutaneous fat necrosis of the newborn (SCFN) is an uncommon condition and may be complicated by hypercalcemia. A 28-day-old neonate, presenting with SCFN, hypercalcemia and nephrocalcinosis was managed with intravenous saline followed by furosemide, oral prednisolone, potassium citrate and etidronate.
authors.affiliation: Department of Pediatric Nephrology and Neonatology, Kanchi Kamakoti CHILDS Trust Hospital, Chennai 600 034, Tamilnadu, India. drmvk@vsnl.net
authors.forename: M
authors.initials: M
authors.lastname: Vijayakumar
authors.forename: N
authors.initials: N
authors.lastname: Prahlad
authors.forename: B R
authors.initials: BR
authors.lastname: Nammalwar
authors.forename: R
authors.initials: R
authors.lastname: Shanmughasundharam
mesh_terms: D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D004232:Diuretics / Q000627:therapeutic use; D012968:Etidronic Acid / Q000627:therapeutic use; D005218:Fat Necrosis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D005665:Furosemide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D009397:Nephrocalcinosis / Q000150:complications; D019357:Potassium Citrate / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012965:Sodium Chloride / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D004232:Diuretics; D005938:Glucocorticoids; D012965:Sodium Chloride; D005665:Furosemide; D011239:Prednisolone; D019357:Potassium Citrate; D012968:Etidronic Acid; D002118:Calcium